India's drug regulator has approved Itolizumab, used to cure skin ailment psoriasis, for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress, officials......
'Safety is my first priority.''I need to ensure that any drug or vaccine that our citizens get is first safe.'Drug Controller General of India Dr V G Somani is a man of action, discovers Sohini......
Kindly note the image has only been posted for representationak reasons. Photograph: Kind courtesy Pixabay Amid controversy surrounding India-made drugs that allegedly caused the deaths of......
India's drug regulator Drugs Controller General of India has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date.......
As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding the COVID-19 vaccines regarding impotency,......
The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective......
With regulatory uncertainties clouding the future of online pharmacies, deals in the space are showing signs of slowdown, as also fresh investment from private-equity (PE) firms and venture......